Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment

Go back to Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
(NASDAQ: DRMA) Delayed: 1.09 -0.01 (0.91%)
Previous Close $1.10    52 Week High
Open $1.10    52 Week Low
Day High $1.11    P/E N/A 
Day Low $1.08    EPS
Volume 12,615